aldoxorubicin tumortargeted doxorubicin conjugate development cytrx specifically hydrazone doxorubicin essentially chemical name describes doxorubicin attached acidsensitive linker nÎµmaleimidocaproic acid hydrazide emch proposed mechanism action follows five phase trials safety characterization completed several phase ii iii trials underway january phase ii clinical trials progress phase iii trial patients relapsed soft tissue sarcoma comparing aldoxorubicin several chemotherapeutics expected complete november cytrx announced preliminary results httpsenwikipediaorgwikialdoxorubicin